Patents by Inventor Renee D. Williman

Renee D. Williman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240131161
    Abstract: Biochemical scaffolds for regulating mammalian cell function. The biochemical scaffolds include a base liquid medium, a bioenergetic platform and a vibrational platform. The bioenergetic platform includes at least one Krebs cycle modulator and/or neurotransmitter modulator. The vibrational platform includes at least one energy signature component, e.g., an herb. The biochemical scaffold is subjected to harmonic oscillation for a defined, predetermined period of time, wherein the energy signature of the energy signature component is imparted to, captured, replicated, and retained by the liquid medium, and, when the biochemical scaffolds are delivered to and, thus, in communication with biological tissue, the biochemical scaffolds induce specific biochemical activities via the resonant transfer of the retained energy signature to the biological tissue and, hence, endogenous cells thereof.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 25, 2024
    Inventors: Ralph L Peterson, Renee D Williman
  • Patent number: 11857626
    Abstract: Biochemical scaffolds for regulating mammalian cell function. The biochemical scaffolds include a base liquid medium, a bioenergetic platform and a vibrational platform. The bioenergetic platform includes at least one Krebs cycle modulator and/or neurotransmitter modulator. The vibrational platform includes at least one energy signature component, e.g., an herb. The biochemical scaffold is subjected to harmonic oscillation for a defined, predetermined period of time, wherein the energy signature of the energy signature component is imparted to, captured, replicated, and retained by the liquid medium, and, when the biochemical scaffolds are delivered to and, thus, in communication with biological tissue, the biochemical scaffolds induce specific biochemical activities via the resonant transfer of the retained energy signature to the biological tissue and, hence, endogenous cells thereof.
    Type: Grant
    Filed: February 20, 2023
    Date of Patent: January 2, 2024
    Assignee: Next2Me, LLC
    Inventors: Ralph L Peterson, Renee D Williman
  • Publication number: 20230201347
    Abstract: Biochemical scaffolds for regulating mammalian cell function. The biochemical scaffolds include a base liquid medium, a bioenergetic platform and a vibrational platform. The bioenergetic platform includes at least one Krebs cycle modulator and/or neurotransmitter modulator. The vibrational platform includes at least one energy signature component, e.g., an herb. The biochemical scaffold is subjected to harmonic oscillation for a defined, predetermined period of time, wherein the energy signature of the energy signature component is imparted to, captured, replicated, and retained by the liquid medium, and, when the biochemical scaffolds are delivered to and, thus, in communication with biological tissue, the biochemical scaffolds induce specific biochemical activities via the resonant transfer of the retained energy signature to the biological tissue and, hence, endogenous cells thereof.
    Type: Application
    Filed: February 20, 2023
    Publication date: June 29, 2023
    Inventors: Ralph L. Peterson, Renee D. Williman
  • Patent number: 11612630
    Abstract: A biochemical scaffold for regulating mammalian cell function. The biochemical scaffold includes a base liquid medium, a bioenergetic platform and a vibrational platform. The bioenergetic platform includes at least one Krebs cycle modulator and the vibrational platform includes at least one energy signature component, e.g., an herb. The biochemical scaffold is subjected to sequential harmonic oscillation at defined frequency ranges for a defined, predetermined period of time, wherein the energy signature of the energy signature component is imparted to, captured, replicated, and retained by liquid medium, and, when the biochemical scaffold is delivered to and, thus, in communication with biological tissue, the biochemical scaffold induces specific biochemical activities via the resonant transfer of the retained energy signature to the biological tissue and, hence, endogenous cells thereof, the biochemical activities including increased bioavailability of ATP.
    Type: Grant
    Filed: October 7, 2022
    Date of Patent: March 28, 2023
    Assignee: Next2Me, LLC
    Inventors: Ralph L Peterson, Renee D Williman
  • Publication number: 20230042908
    Abstract: A biochemical scaffold for regulating mammalian cell function. The biochemical scaffold includes a base liquid medium, a bioenergetic platform and a vibrational platform. The bioenergetic platform includes at least one Krebs cycle modulator and the vibrational platform includes at least one energy signature component, e.g., an herb. The biochemical scaffold is subjected to sequential harmonic oscillation at defined frequency ranges for a defined, predetermined period of time, wherein the energy signature of the energy signature component is imparted to, captured, replicated, and retained by liquid medium, and, when the biochemical scaffold is delivered to and, thus, in communication with biological tissue, the biochemical scaffold induces specific biochemical activities via the resonant transfer of the retained energy signature to the biological tissue and, hence, endogenous cells thereof, the biochemical activities including increased bioavailability of ATP.
    Type: Application
    Filed: October 7, 2022
    Publication date: February 9, 2023
    Inventors: Ralph L. Peterson, Renee D. Williman
  • Patent number: 11529383
    Abstract: A method for modulating cellular activity in a subject, consisting essentially of the steps: (i) forming a liquid composition, (ii) subjecting the liquid composition to sequential harmonic oscillation to provide a liquid biochemical scaffold and, (iii) delivering a therapeutically effective amount of said liquid biochemical scaffold to said subject.
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: December 20, 2022
    Assignee: Next2Me, LLC
    Inventors: Ralph L Peterson, Renee D Williman
  • Publication number: 20220257682
    Abstract: A biochemical scaffold for regulating mammalian cell function, including a bioenergetic platform and a vibrational platform, the bioenergetic platform comprising a Krebs cycle modulator and/or glutathione modulator and/or neurotransmitter modulator and/or DNA modulator and/or endocannabinoid system modulator, the vibrational platform comprising at least one energy signature component, e.g., herb, that is subjected to continued or steady state harmonic oscillation at a frequency in the range of approximately 23 Hz-1000 GHz for a period of time in the range of approximately 3-48 hrs. or sequential harmonic oscillation at frequencies in the range of approximately 0.9 kHz-1.5 kHz for a period of time in the range of approximately 3-60 minutes, approximately 9.5 kHz-10.5 kHz for a period of time in the range of approximately 3-60 minutes, approximately 9.5 kHz-11.0 kHz for a period of time in the range of approximately 3-60 minutes, approximately 0.01 kHz-0.
    Type: Application
    Filed: April 29, 2022
    Publication date: August 18, 2022
    Inventors: Ralph L. Peterson, Renee D. Williman
  • Publication number: 20180369272
    Abstract: A biochemical scaffold for regulating mammalian cell function, including a bioenergetic platform and a vibrational platform, the bioenergetic platform comprising a Krebs cycle modulator and/or glutathione modulator and/or neurotransmitter modulator and/or DNA modulator and/or endocannabinoid system modulator, the vibrational platform comprising at least one energy signature component, e.g. herb, that is subjected to harmonic oscillation in the range of approximately 23 Hz-1000 GHz for a period of time in the range of approximately 3-48 hrs.
    Type: Application
    Filed: August 29, 2018
    Publication date: December 27, 2018
    Inventors: Ralph L. Peterson, Renee D. Williman
  • Publication number: 20150216923
    Abstract: A biochemical scaffold for regulating mammalian cell function, including a bioenergetic platform and a vibrational platform, the bioenergetic platform comprising a Krebs cycle modulator, glutathione modulator, neurotransmitter modulator and a DNA modulator, the vibrational platform comprising a plurality of herbs that are subjected to harmonic oscillation in the range of approximately 102 GHz-250 GHz for a period of time in the range of approximately 3-5 hrs.
    Type: Application
    Filed: March 24, 2014
    Publication date: August 6, 2015
    Inventors: Ralph L. Peterson, Renee D. Williman, Seth L. Forster